Showing results (31-40 of 68) with videos related to
Sort By:
Pageof 7
RSC Advances|April 15, 2022
Phenylalanyl tRNA synthetase (PheRS) substrate mimics: design, synthesis, molecular dynamics and antimicrobial evaluationNada A Noureldin, Jennifer Richards, Hend Kothayer, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|April 10, 2003
Some 3-(4-aminophenyl)pyrrolidine-2,5-diones as all-trans-retinoic acid metabolising enzyme inhibitors (RAMBAs)Andrew J Kirby, Regis Lelain, Peter Mason, et al.BMC Chemistry|October 29, 2021
Design, computational studies, synthesis and in vitro antimicrobial evaluation of benzimidazole based thio-oxadiazole and thio-thiadiazole analoguesNada A Noureldin, Jennifer Richards, Hend Kothayer, et al.European Journal of Medicinal Chemistry|September 21, 2014
Novel styryl-indoles as small molecule inhibitors of 25-hydroxyvitamin D-24-hydroxylase (CYP24A1): Synthesis and biological evaluationSalvatore Ferla, Mohamed S Gomaa, Andrea Brancale, et al.Journal of Medicinal Chemistry|February 3, 2006
Potent CYP19 (aromatase) 1-[(benzofuran-2-yl)(phenylmethyl)pyridine, -imidazole, and -triazole inhibitors: synthesis and biological evaluationMohammed Reza Saberi, Tai Ky Vinh, Sook Wah Yee, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|May 20, 2003
Inhibition of retinoic acid metabolising enzymes by 2-(4-aminophenylmethyl)-6-hydroxy-3,4-dihydronaphthalen-1(2H)-one and related compoundsAndrew J Kirby, Regis Le Lain, Farshid Maharlouie, et al.Journal of Molecular Graphics & Modelling|February 26, 2017
Exploring the binding sites of Staphylococcus aureus phenylalanine tRNA synthetase: A homology model approachSamar S Elbaramawi, Samy M Ibrahim, El-Sayed M Lashine, et al.Bioorganic & Medicinal Chemistry|August 30, 2008
Novel azolyl-(phenylmethyl)]aryl/heteroarylamines: potent CYP26 inhibitors and enhancers of all-trans retinoic acid activity in neuroblastoma cellsMohamed Sayed Gomaa, Jane L Armstrong, Beatrice Bobillon, et al.Advances in Therapy|November 19, 2021
An Innovative Approach to Modelling the Optimal Treatment Sequence for Patients with Relapsing-Remitting Multiple Sclerosis: Implementation, Validation, and Impact of the Decision-Making ApproachMarjanne A Piena, Sonja Kroep, Claire Simons, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|August 27, 2005
Effect of 2-(4-aminophenylmethyl)-6-hydroxy-3, 4-dihydronaphthalen-1(2H)-one on all-trans and 13-cis-retinoic acid levels in plasma quantified by high perfomance liquid chromatography coupled to tandem mass spectrometryMarc Angotti, Rolf W Hartmann, Andrew J Kirby, et al.Pageof 7